The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions Market Shows Positive Growth due to the Launch of New Drugs for the Treatment of Brain Tumor
- Advertising -
A brain tumor is an abnormal growth of cells in the tissue of the brain. It can be cancerous (malignant) and non-cancerous (benign).
The growth rate of the brain tumor affects the nervous system of the brain. Malignant brain tumor cells contain cancer cells and they do not have any clear border.
- Advertising -
It has a clear border and does not spread into other tissues. There are two types of brain tumor: primary brain tumor and secondary brain tumor.
The primary brain tumor starts from the brain and may spread to other parts of the brain or spine but rarely spreads to other organs of the body. The secondary brain tumor starts from other part of the body and then spreads to the brain.
The secondary brain tumor is more common as compared to the primary brain tumor. Family history, age, race, and exposure to radiation and chemicals are some of the risk factors of the disease.
The treatment options depend upon the size and location of the tumor.
Read the Comprehensive Overview of Brain Tumor Treatment Market: www.transparencymarketresearch.com/brain-tumor-treatment-market.html
Based on treatment, the global brain tumor treatment market can be segmented into drug therapy and surgery. A brain tumor treatment usually starts with drugs such as everolimus, bevacizumab, and carmustine.
Modern surgical equipment allows a surgeon to locate a tumor and remove the tumor. The drug therapy segment is further categorized as chemotherapy and targeted therapy.
On the basis of diagnosis, the market is classified as CT scan, PET-CT scan, molecular testing of tumor, cerebral arteriogram, and myelogram. The increase in incidence rate of brain tumor in recent decades is one of the major factors driving the global market.
In addition, rise in geriatric population and launch of new drugs for the treatment of brain tumor are other factors that are fueling the growth of the market. However, limited availability of drugs specific to the brain tumor treatment, high cost of therapy and side-effect associated with it, and increase in use of generics in chemotherapy are hampering the growth of the brain tumor treatment market.
Geographically, the global market for brain tumor treatment is distributed over North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America dominates the global market owing to high incidence rate of brain tumor, improved treatment options, and developed health care infrastructure.
In Europe, the European Medicines Agency (EMA) is associated with many pharmaceutical companies to evaluate drugs for the treatment of brain tumor and ensure the protection of public health with proper supervision of these drugs. This factor helps in driving the growth of the Europe market.
Asia Pacific is a less mature but an emerging market owing to developing health care infrastructure, growing patient awareness, and increasing government expenditure. In Middle East & Africa, the ongoing clinical trials and established medical support help the market to expand.
Major players operating in the global brain tumor treatment market include Pfizer Inc., Bayer HealthCare Pharmaceuticals Inc., F. Hoffmann-La Roche AG, AstraZeneca plc, Novartis International AG, Merck & Co., and Dr.
Category: Market Research Publishers and RetailersCompany profile: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements. We specialize in the following areas: Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...
For more information: